Bio-Rad to Report Fourth-Quarter and Full-Year 2018 Financial Results Thursday, February 28, 2019

HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of
life science research and clinical diagnostic products, will report
financial results for the fourth quarter and full year 2018 on Thursday,
February 28, 2019, following the close of the market. The company will
discuss these results in a conference call scheduled for 2 PM Pacific
Time (5 PM Eastern Time) that day.

To listen, call 855-779-9068 within the U.S. or 631-485-4862 outside the
U.S., conference ID: 9099577. You may also listen to the
conference call live via a webcast that is available on the “Investor
Relations” section of our website under “Quarterly Results” at
The webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in
developing, manufacturing, and marketing a broad range of innovative
products for the life science research and clinical diagnostic markets.
With a focus on quality and customer service for over 65 years, our
products advance the discovery process and improve healthcare. Our
customers are university and research institutions, hospitals, public
health and commercial laboratories, biotechnology, pharmaceutical, as
well as applied laboratories that include food safety and environmental
quality. Founded in 1952, Bio-Rad is based in Hercules, California, and
has a global network of operations with more than 8,000 employees
worldwide. Bio-Rad had revenues exceeding $2.1 billion in 2017. For more
information, please visit


Investor and Financial Contacts:
Christine Tsingos,
Executive Vice President and Chief Financial Officer
Ron Hutton,
Vice President and Treasurer
Bio-Rad Laboratories, Inc.

error: Content is protected !!